Peripheral	JJ	B-NP	B-cell_type	Other	Other	Other	Other	Other	###	1	Peripheral	Peripheral	JJ	JJ	_	4	amod	_	_
blood	NN	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	2	blood	blood	NN	NN	_	4	compound	_	_
mononuclear	JJ	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	3	mononuclear	mononuclear	JJ	JJ	_	4	amod	_	_
cells	NNS	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	4	cells	cells	NNS	NNS	_	11	nsubj	_	_
isolated	VBN	B-VP	O	Other	Other	Other	Other	Other	###	5	isolated	isolated	VBN	VBN	_	4	acl	_	_
from	IN	B-PP	O	Other	Other	Other	Other	Other	###	6	from	from	IN	IN	_	7	case	_	_
patients	NNS	B-NP	O	Other	Other	Other	Other	Other	###	7	patients	patients	NNS	NNS	_	5	nmod	_	_
with	IN	B-PP	O	Other	Other	Other	Other	Other	###	8	with	with	IN	IN	_	10	case	_	_
diabetic	JJ	B-NP	O	Other	Other	Other	Other	Other	###	9	diabetic	diabetic	JJ	JJ	_	10	amod	_	_
nephropathy	NN	I-NP	O	Other	Other	Other	Other	Other	###	10	nephropathy	nephropathy	NN	NN	_	7	nmod	_	_
show	VBP	B-VP	O	Other	Other	Other	Other	Other	###	11	show	show	VBP	VBP	_	0	root	_	_
increased	VBN	B-NP	O	Other	Other	Other	Other	Other	###	12	increased	increased	VBN	VBN	_	13	amod	_	_
activation	NN	I-NP	O	Other	Other	Other	Other	Other	###	13	activation	activation	NN	NN	_	11	dobj	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	14	of	of	IN	IN	_	20	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	15	the	the	DT	DT	_	20	det	_	_
oxidative-stress	NN	I-NP	B-protein	Other	Other	Other	Other	Other	###	16	oxidative-stress	oxidative-stress	NN	NN	_	20	compound	_	_
sensitive	JJ	I-NP	I-protein	Other	Other	Other	Other	Other	###	17	sensitive	sensitive	JJ	JJ	_	20	amod	_	_
transcription	NN	I-NP	I-protein	Other	Other	Other	Other	Other	###	18	transcription	transcription	NN	NN	_	20	compound	_	_
factor	NN	I-NP	I-protein	Other	Other	Other	Other	Other	###	19	factor	factor	NN	NN	_	20	compound	_	_
NF-kappaB	NN	I-NP	B-protein	Other	Other	Other	Other	Other	###	20	NF-kappaB	NF-kappaB	NN	NN	_	13	nmod	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	21	.	.	.	.	_	11	punct	_	_

Increased	VBN	B-NP	O	Other	Other	Other	Other	Other	###	1	Increased	Increased	VBN	VBN	_	3	amod	_	_
oxidative	JJ	I-NP	O	Other	Other	Other	Other	Other	###	2	oxidative	oxidative	JJ	JJ	_	3	amod	_	_
stress	NN	I-NP	O	Other	Other	Other	Other	Other	###	3	stress	stress	NN	NN	_	14	nsubjpass	_	_
and	CC	O	O	Other	Other	Other	Other	Other	###	4	and	and	CC	CC	_	3	cc	_	_
subsequent	JJ	B-NP	O	Other	Other	Other	Other	Other	###	5	subsequent	subsequent	JJ	JJ	_	6	amod	_	_
activation	NN	I-NP	O	Other	Other	Other	Other	Other	###	6	activation	activation	NN	NN	_	3	conj	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	7	of	of	IN	IN	_	11	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	8	the	the	DT	DT	_	11	det	_	_
transcription	NN	I-NP	B-protein	Other	Other	Other	Other	Other	###	9	transcription	transcription	NN	NN	_	11	compound	_	_
factor	NN	I-NP	I-protein	Other	Other	Other	Other	Other	###	10	factor	factor	NN	NN	_	11	compound	_	_
NF-kappaB	NN	I-NP	B-protein	Other	Other	Other	Other	Other	###	11	NF-kappaB	NF-kappaB	NN	NN	_	3	nmod	_	_
has	VBZ	B-VP	O	Other	Other	Other	Other	Other	###	12	has	has	VBZ	VBZ	_	14	aux	_	_
been	VBN	I-VP	O	Other	Other	Other	Other	Other	###	13	been	been	VBN	VBN	_	14	auxpass	_	_
linked	VBN	I-VP	O	Other	Other	Other	Other	Other	###	14	linked	linked	VBN	VBN	_	0	root	_	_
to	TO	B-PP	O	Other	Other	Other	Other	Other	###	15	to	to	TO	TO	_	17	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	16	the	the	DT	DT	_	17	det	_	_
development	NN	I-NP	O	Other	Other	Other	Other	Other	###	17	development	development	NN	NN	_	14	nmod	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	18	of	of	IN	IN	_	21	case	_	_
late	JJ	B-NP	O	Other	Other	Other	Other	Other	###	19	late	late	JJ	JJ	_	21	amod	_	_
diabetic	JJ	I-NP	O	Other	Other	Other	Other	Other	###	20	diabetic	diabetic	JJ	JJ	_	21	amod	_	_
complications	NNS	I-NP	O	Other	Other	Other	Other	Other	###	21	complications	complications	NNS	NNS	_	17	nmod	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	22	.	.	.	.	_	14	punct	_	_

To	TO	B-VP	O	Other	Other	Other	Other	Other	###	1	To	To	TO	TO	_	2	mark	_	_
determine	VB	I-VP	O	Other	Other	Other	Other	Other	###	2	determine	determine	VB	VB	_	17	dep	_	_
whether	IN	B-SBAR	O	Other	Other	Other	Other	Other	###	3	whether	whether	IN	IN	_	10	mark	_	_
oxidative	JJ	B-NP	O	Other	Other	Other	Other	Other	###	4	oxidative	oxidative	JJ	JJ	_	6	amod	_	_
stress	NN	I-NP	O	Other	Other	Other	Other	Other	###	5	stress	stress	NN	NN	_	6	nmod:npmod	_	_
dependent	JJ	I-NP	O	Other	Other	Other	Other	Other	###	6	dependent	dependent	JJ	JJ	_	8	amod	_	_
NF-kappaB	NN	I-NP	B-protein	Other	Other	Other	Other	Other	###	7	NF-kappaB	NF-kappaB	NN	NN	_	8	compound	_	_
activation	NN	I-NP	O	Other	Other	Other	Other	Other	###	8	activation	activation	NN	NN	_	10	nsubj	_	_
is	VBZ	B-VP	O	Other	Other	Other	Other	Other	###	9	is	is	VBZ	VBZ	_	10	cop	_	_
evident	JJ	B-ADJP	O	Other	Other	Other	Other	Other	###	10	evident	evident	JJ	JJ	_	2	ccomp	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	11	in	in	IN	IN	_	12	case	_	_
patients	NNS	B-NP	O	Other	Other	Other	Other	Other	###	12	patients	patients	NNS	NNS	_	10	nmod	_	_
with	IN	B-PP	O	Other	Other	Other	Other	Other	###	13	with	with	IN	IN	_	15	case	_	_
diabetic	JJ	B-NP	O	Other	Other	Other	Other	Other	###	14	diabetic	diabetic	JJ	JJ	_	15	amod	_	_
nephropathy	NN	I-NP	O	Other	Other	Other	Other	Other	###	15	nephropathy	nephropathy	NN	NN	_	12	nmod	_	_
we	PRP	B-NP	O	Other	Other	Other	Other	Other	###	16	we	we	PRP	PRP	_	17	nsubj	_	_
used	VBD	B-VP	O	Other	Other	Other	Other	Other	###	17	used	used	VBD	VBD	_	0	root	_	_
an	DT	B-NP	O	Other	Other	Other	Other	Other	###	18	an	an	DT	DT	_	26	det	_	_
Electrophoretic	JJ	I-NP	O	Other	Other	Other	Other	Other	###	19	Electrophoretic	Electrophoretic	JJ	JJ	_	23	amod	_	_
Mobility	NN	I-NP	O	Other	Other	Other	Other	Other	###	20	Mobility	Mobility	NN	NN	_	23	nmod:npmod	_	_
Shift	NN	I-NP	O	Other	Other	Other	Other	Other	###	21	Shift	Shift	NN	NN	_	23	nmod:npmod	_	_
Assay	NN	I-NP	O	Other	Other	Other	Other	Other	###	22	Assay	Assay	NN	NN	_	23	nmod:npmod	_	_
based	JJ	I-NP	O	Other	Other	Other	Other	Other	###	23	based	based	JJ	JJ	_	26	amod	_	_
semiquantitative	JJ	I-NP	O	Other	Other	Other	Other	Other	###	24	semiquantitative	semiquantitative	JJ	JJ	_	26	amod	_	_
detection	NN	I-NP	O	Other	Other	Other	Other	Other	###	25	detection	detection	NN	NN	_	26	compound	_	_
system	NN	I-NP	O	Other	Other	Other	Other	Other	###	26	system	system	NN	NN	_	17	dobj	_	_
which	WDT	B-NP	O	Other	Other	Other	Other	Other	###	27	which	which	WDT	WDT	_	28	nsubj	_	_
enabled	VBD	B-VP	O	Other	Other	Other	Other	Other	###	28	enabled	enabled	VBD	VBD	_	26	acl:relcl	_	_
us	PRP	B-NP	O	Other	Other	Other	Other	Other	###	29	us	us	PRP	PRP	_	28	dobj	_	_
to	TO	B-VP	O	Other	Other	Other	Other	Other	###	30	to	to	TO	TO	_	31	mark	_	_
determine	VB	I-VP	O	Other	Other	Other	Other	Other	###	31	determine	determine	VB	VB	_	28	xcomp	_	_
NF-kappaB	NN	B-NP	B-protein	Other	Other	Other	Other	Other	###	32	NF-kappaB	NF-kappaB	NN	NN	_	33	compound	_	_
activation	NN	I-NP	O	Other	Other	Other	Other	Other	###	33	activation	activation	NN	NN	_	31	dobj	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	34	in	in	IN	IN	_	41	case	_	_
ex	FW	B-ADVP	O	Other	Other	Other	Other	Other	###	35	ex	ex	FW	FW	_	41	amod	_	_
vivo	FW	I-ADVP	O	Other	Other	Other	Other	Other	###	36	vivo	vivo	FW	FW	_	35	dep	_	_
isolated	VBN	B-NP	B-cell_type	Other	Other	Other	Other	Other	###	37	isolated	isolated	VBN	VBN	_	41	amod	_	_
peripheral	JJ	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	38	peripheral	peripheral	JJ	JJ	_	41	amod	_	_
blood	NN	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	39	blood	blood	NN	NN	_	41	compound	_	_
mononuclear	JJ	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	40	mononuclear	mononuclear	JJ	JJ	_	41	amod	_	_
cells	NNS	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	41	cells	cells	NNS	NNS	_	33	nmod	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	42	.	.	.	.	_	17	punct	_	_

We	PRP	B-NP	O	Other	Other	Other	Other	Other	###	1	We	We	PRP	PRP	_	2	nsubj	_	_
examined	VBD	B-VP	O	Other	Other	Other	Other	Other	###	2	examined	examined	VBD	VBD	_	0	root	_	_
33	CD	B-NP	O	Other	Other	Other	Other	Other	###	3	33	33	CD	CD	_	4	nummod	_	_
patients	NNS	I-NP	O	Other	Other	Other	Other	Other	###	4	patients	patients	NNS	NNS	_	2	dobj	_	_
with	IN	B-PP	O	Other	Other	Other	Other	Other	###	5	with	with	IN	IN	_	7	case	_	_
diabetes	NN	B-NP	O	Other	Other	Other	Other	Other	###	6	diabetes	diabetes	NN	NN	_	7	compound	_	_
mellitus	NN	I-NP	O	Other	Other	Other	Other	Other	###	7	mellitus	mellitus	NN	NN	_	4	nmod	_	_
(	(	O	O	Other	Other	Other	Other	Other	###	8	(	(	(	(	_	9	punct	_	_
Type	NN	B-NP	O	Other	Other	Other	Other	Other	###	9	Type	Type	NN	NN	_	4	dep	_	_
I	CD	I-NP	O	Other	Other	Other	Other	Other	###	10	I	I	CD	CD	_	9	nummod	_	_
and	CC	O	O	Other	Other	Other	Other	Other	###	11	and	and	CC	CC	_	9	cc	_	_
Type	NN	B-NP	O	Other	Other	Other	Other	Other	###	12	Type	Type	NN	NN	_	9	conj	_	_
II	CD	I-NP	O	Other	Other	Other	Other	Other	###	13	II	II	CD	CD	_	12	nummod	_	_
)	)	O	O	Other	Other	Other	Other	Other	###	14	)	)	)	)	_	9	punct	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	15	.	.	.	.	_	2	punct	_	_

Patients	NNS	B-NP	O	Other	Other	Other	Other	Other	###	1	Patients	Patients	NNS	NNS	_	5	nsubj	_	_
with	IN	B-PP	O	Other	Other	Other	Other	Other	###	2	with	with	IN	IN	_	4	case	_	_
diabetic	JJ	B-NP	O	Other	Other	Other	Other	Other	###	3	diabetic	diabetic	JJ	JJ	_	4	amod	_	_
nephropathy	NN	I-NP	O	Other	Other	Other	Other	Other	###	4	nephropathy	nephropathy	NN	NN	_	1	nmod	_	_
showed	VBD	B-VP	O	Other	Other	Other	Other	Other	###	5	showed	showed	VBD	VBD	_	0	root	_	_
higher	JJR	B-NP	O	Other	Other	Other	Other	Other	###	6	higher	higher	JJR	JJR	_	9	amod	_	_
NF-kappaB	NN	I-NP	B-protein	Other	Other	Other	Other	Other	###	7	NF-kappaB	NF-kappaB	NN	NN	_	9	compound	_	_
binding	NN	I-NP	O	Other	Other	Other	Other	Other	###	8	binding	binding	NN	NN	_	9	compound	_	_
activity	NN	I-NP	O	Other	Other	Other	Other	Other	###	9	activity	activity	NN	NN	_	5	dobj	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	10	in	in	IN	IN	_	14	case	_	_
Electrophoretic	JJ	B-NP	O	Other	Other	Other	Other	Other	###	11	Electrophoretic	Electrophoretic	JJ	JJ	_	14	amod	_	_
Mobility	NN	I-NP	O	Other	Other	Other	Other	Other	###	12	Mobility	Mobility	NN	NN	_	14	compound	_	_
Shift	NN	I-NP	O	Other	Other	Other	Other	Other	###	13	Shift	Shift	NN	NN	_	14	compound	_	_
Assays	NNS	I-NP	O	Other	Other	Other	Other	Other	###	14	Assays	Assays	NNS	NNS	_	9	nmod	_	_
and	CC	O	O	Other	Other	Other	Other	Other	###	15	and	and	CC	CC	_	9	cc	_	_
stronger	JJR	B-NP	O	Other	Other	Other	Other	B-Positive_regulation	###	16	stronger	stronger	JJR	JJR	_	18	amod	_	_
immunohistological	JJ	I-NP	O	Other	Other	Other	Other	Other	###	17	immunohistological	immunohistological	JJ	JJ	_	18	amod	_	_
staining	NN	I-NP	O	Other	Other	Other	Other	Other	###	18	staining	staining	NN	NN	_	9	conj	_	_
for	IN	B-PP	O	Other	Other	Other	Other	Other	###	19	for	for	IN	IN	_	21	case	_	_
activated	VBN	B-NP	O	Other	Other	Other	Other	B-Positive_regulation	###	20	activated	activated	VBN	VBN	_	21	amod	_	_
NF-kappaBp65	NN	I-NP	B-protein	B-Protein	Other	Other	B-Protein	Other	###	21	NF-kappaBp65	NF-kappaBp65	NN	NN	_	18	nmod	_	_
than	IN	B-PP	O	Other	Other	Other	Other	Other	###	22	than	than	IN	IN	_	23	case	_	_
patients	NNS	B-NP	O	Other	Other	Other	Other	Other	###	23	patients	patients	NNS	NNS	_	18	nmod	_	_
without	IN	B-PP	O	Other	Other	Other	Other	Other	###	24	without	without	IN	IN	_	26	case	_	_
renal	JJ	B-NP	O	Other	Other	Other	Other	Other	###	25	renal	renal	JJ	JJ	_	26	amod	_	_
complications	NNS	I-NP	O	Other	Other	Other	Other	Other	###	26	complications	complications	NNS	NNS	_	23	nmod	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	27	.	.	.	.	_	5	punct	_	_

NF-kappaB	NN	B-NP	B-protein	Other	Other	Other	Other	Other	###	1	NF-kappaB	NF-kappaB	NN	NN	_	3	compound	_	_
binding	NN	I-NP	O	Other	Other	Other	Other	Other	###	2	binding	binding	NN	NN	_	3	compound	_	_
activity	NN	I-NP	O	Other	Other	Other	Other	Other	###	3	activity	activity	NN	NN	_	4	nsubj	_	_
correlated	VBD	B-VP	O	Other	Other	Other	Other	Other	###	4	correlated	correlated	VBD	VBD	_	0	root	_	_
with	IN	B-PP	O	Other	Other	Other	Other	Other	###	5	with	with	IN	IN	_	7	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	6	the	the	DT	DT	_	7	det	_	_
degree	NN	I-NP	O	Other	Other	Other	Other	Other	###	7	degree	degree	NN	NN	_	4	nmod	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	8	of	of	IN	IN	_	9	case	_	_
albuminuria	NN	B-NP	O	Other	Other	Other	Other	Other	###	9	albuminuria	albuminuria	NN	NN	_	7	nmod	_	_
(	(	O	O	Other	Other	Other	Other	Other	###	10	(	(	(	(	_	12	punct	_	_
r	NN	B-NP	O	Other	Other	Other	Other	Other	###	11	r	r	NN	NN	_	12	nsubj	_	_
=	SYM	B-VP	O	Other	Other	Other	Other	Other	###	12	=	=	SYM	SYM	_	9	dep	_	_
0.316	CD	B-NP	O	Other	Other	Other	Other	Other	###	13	0.316	0.316	CD	CD	_	12	dobj	_	_
)	)	O	O	Other	Other	Other	Other	Other	###	14	)	)	)	)	_	12	punct	_	_
and	CC	O	O	Other	Other	Other	Other	Other	###	15	and	and	CC	CC	_	7	cc	_	_
with	IN	B-PP	O	Other	Other	Other	Other	Other	###	16	with	with	IN	IN	_	19	case	_	_
thrombomodulin	NN	B-NP	B-protein	B-Protein	Other	Other	Other	Other	###	17	thrombomodulin	thrombomodulin	NN	NN	_	19	compound	_	_
plasma	NN	I-NP	O	Other	Other	Other	Other	Other	###	18	plasma	plasma	NN	NN	_	19	compound	_	_
concentrations	NNS	I-NP	O	Other	Other	Other	Other	Other	###	19	concentrations	concentrations	NNS	NNS	_	7	conj	_	_
(	(	O	O	Other	Other	Other	Other	Other	###	20	(	(	(	(	_	22	punct	_	_
r	NN	B-NP	O	Other	Other	Other	Other	Other	###	21	r	r	NN	NN	_	22	nsubj	_	_
=	SYM	B-VP	O	Other	Other	Other	Other	Other	###	22	=	=	SYM	SYM	_	19	dep	_	_
0.33	CD	B-NP	O	Other	Other	Other	Other	Other	###	23	0.33	0.33	CD	CD	_	22	dobj	_	_
)	)	O	O	Other	Other	Other	Other	Other	###	24	)	)	)	)	_	22	punct	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	25	,	,	,	,	_	4	punct	_	_
indicative	JJ	B-ADJP	O	Other	Other	Other	Other	Other	###	26	indicative	indicative	JJ	JJ	_	4	xcomp	_	_
for	IN	B-PP	O	Other	Other	Other	Other	Other	###	27	for	for	IN	IN	_	31	case	_	_
albuminuria	NN	B-NP	O	Other	Other	Other	Other	Other	###	28	albuminuria	albuminuria	NN	NN	_	29	nmod:npmod	_	_
associated	JJ	I-NP	O	Other	Other	Other	Other	Other	###	29	associated	associated	JJ	JJ	_	31	amod	_	_
endothelial	JJ	I-NP	O	Other	Other	Other	Other	Other	###	30	endothelial	endothelial	JJ	JJ	_	31	amod	_	_
dysfunction	NN	I-NP	O	Other	Other	Other	Other	Other	###	31	dysfunction	dysfunction	NN	NN	_	26	nmod	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	32	.	.	.	.	_	4	punct	_	_

In	IN	B-PP	O	Other	Other	Other	Other	Other	###	1	In	In	IN	IN	_	6	case	_	_
a	DT	B-NP	O	Other	Other	Other	Other	Other	###	2	a	a	DT	DT	_	6	det	_	_
3	CD	I-NP	O	Other	Other	Other	Other	Other	###	3	3	3	CD	CD	_	4	compound	_	_
day	NN	I-NP	O	Other	Other	Other	Other	Other	###	4	day	day	NN	NN	_	6	amod	_	_
intervention	NN	I-NP	O	Other	Other	Other	Other	Other	###	5	intervention	intervention	NN	NN	_	6	compound	_	_
study	NN	I-NP	O	Other	Other	Other	Other	Other	###	6	study	study	NN	NN	_	36	nmod	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	7	in	in	IN	IN	_	8	case	_	_
which	WDT	B-NP	O	Other	Other	Other	Other	Other	###	8	which	which	WDT	WDT	_	23	nmod	_	_
600	CD	B-NP	O	Other	Other	Other	Other	Other	###	9	600	600	CD	CD	_	10	nummod	_	_
mg	NN	I-NP	O	Other	Other	Other	Other	Other	###	10	mg	mg	NN	NN	_	23	nsubjpass	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	11	of	of	IN	IN	_	15	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	12	the	the	DT	DT	_	15	det	_	_
antioxidant	JJ	I-NP	O	Other	Other	Other	Other	Other	###	13	antioxidant	antioxidant	JJ	JJ	_	15	amod	_	_
thioctic	JJ	I-NP	O	Other	Other	Other	Other	Other	###	14	thioctic	thioctic	JJ	JJ	_	15	amod	_	_
acid	NN	I-NP	O	Other	Other	Other	Other	Other	###	15	acid	acid	NN	NN	_	10	nmod	_	_
(	(	O	O	Other	Other	Other	Other	Other	###	16	(	(	(	(	_	18	punct	_	_
alpha-lipoic	JJ	B-NP	O	Other	Other	Other	Other	Other	###	17	alpha-lipoic	alpha-lipoic	JJ	JJ	_	18	amod	_	_
acid	NN	I-NP	O	Other	Other	Other	Other	Other	###	18	acid	acid	NN	NN	_	15	appos	_	_
)	)	O	O	Other	Other	Other	Other	Other	###	19	)	)	)	)	_	18	punct	_	_
per	IN	B-NP	O	Other	Other	Other	Other	Other	###	20	per	per	IN	IN	_	21	case	_	_
day	NN	I-NP	O	Other	Other	Other	Other	Other	###	21	day	day	NN	NN	_	10	nmod	_	_
were	VBD	B-VP	O	Other	Other	Other	Other	Other	###	22	were	were	VBD	VBD	_	23	auxpass	_	_
given	VBN	I-VP	O	Other	Other	Other	Other	Other	###	23	given	given	VBN	VBN	_	6	acl:relcl	_	_
to	TO	B-PP	O	Other	Other	Other	Other	Other	###	24	to	to	TO	TO	_	26	case	_	_
nine	CD	B-NP	O	Other	Other	Other	Other	Other	###	25	nine	nine	CD	CD	_	26	nummod	_	_
patients	NNS	I-NP	O	Other	Other	Other	Other	Other	###	26	patients	patients	NNS	NNS	_	23	nmod	_	_
with	IN	B-PP	O	Other	Other	Other	Other	Other	###	27	with	with	IN	IN	_	29	case	_	_
diabetic	JJ	B-NP	O	Other	Other	Other	Other	Other	###	28	diabetic	diabetic	JJ	JJ	_	29	amod	_	_
nephropathy	NN	I-NP	O	Other	Other	Other	Other	Other	###	29	nephropathy	nephropathy	NN	NN	_	26	nmod	_	_
oxidative	JJ	I-NP	O	Other	Other	Other	Other	Other	###	30	oxidative	oxidative	JJ	JJ	_	31	amod	_	_
stress	NN	I-NP	O	Other	Other	Other	Other	Other	###	31	stress	stress	NN	NN	_	36	nsubjpass	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	32	in	in	IN	IN	_	34	case	_	_
plasma	NN	B-NP	O	Other	Other	Other	Other	Other	###	33	plasma	plasma	NN	NN	_	34	compound	_	_
samples	NNS	I-NP	O	Other	Other	Other	Other	Other	###	34	samples	samples	NNS	NNS	_	31	nmod	_	_
was	VBD	B-VP	O	Other	Other	Other	Other	Other	###	35	was	was	VBD	VBD	_	36	auxpass	_	_
decreased	VBN	I-VP	O	Other	Other	Other	Other	Other	###	36	decreased	decreased	VBN	VBN	_	0	root	_	_
by	IN	B-PP	O	Other	Other	Other	Other	Other	###	37	by	by	IN	IN	_	39	case	_	_
48	CD	B-NP	O	Other	Other	Other	Other	Other	###	38	48	48	CD	CD	_	39	nummod	_	_
%	NN	I-NP	O	Other	Other	Other	Other	Other	###	39	%	%	NN	NN	_	36	nmod	_	_
and	CC	I-NP	O	Other	Other	Other	Other	Other	###	40	and	and	CC	CC	_	36	cc	_	_
NF-kappaB	NN	I-NP	B-protein	Other	Other	Other	Other	Other	###	41	NF-kappaB	NF-kappaB	NN	NN	_	43	compound	_	_
binding	NN	I-NP	O	Other	Other	Other	Other	Other	###	42	binding	binding	NN	NN	_	43	compound	_	_
activity	NN	I-NP	O	Other	Other	Other	Other	Other	###	43	activity	activity	NN	NN	_	36	conj	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	44	in	in	IN	IN	_	51	case	_	_
ex	FW	B-ADVP	O	Other	Other	Other	Other	Other	###	45	ex	ex	FW	FW	_	51	amod	_	_
vivo	FW	I-ADVP	O	Other	Other	Other	Other	Other	###	46	vivo	vivo	FW	FW	_	45	dep	_	_
isolated	VBN	B-NP	B-cell_type	Other	Other	Other	Other	Other	###	47	isolated	isolated	VBN	VBN	_	51	amod	_	_
peripheral	JJ	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	48	peripheral	peripheral	JJ	JJ	_	51	amod	_	_
blood	NN	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	49	blood	blood	NN	NN	_	51	compound	_	_
mononuclear	JJ	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	50	mononuclear	mononuclear	JJ	JJ	_	51	amod	_	_
cells	NNS	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	51	cells	cells	NNS	NNS	_	43	nmod	_	_
by	IN	B-PP	O	Other	Other	Other	Other	Other	###	52	by	by	IN	IN	_	54	case	_	_
38	CD	B-NP	O	Other	Other	Other	Other	Other	###	53	38	38	CD	CD	_	54	nummod	_	_
%	NN	I-NP	O	Other	Other	Other	Other	Other	###	54	%	%	NN	NN	_	43	dep	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	55	.	.	.	.	_	36	punct	_	_

In	IN	B-PP	O	Other	Other	Other	Other	Other	###	1	In	In	IN	IN	_	2	case	_	_
conclusion	NN	B-NP	O	Other	Other	Other	Other	Other	###	2	conclusion	conclusion	NN	NN	_	23	nmod	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	3	,	,	,	,	_	23	punct	_	_
activation	NN	B-NP	O	Other	Other	Other	Other	Other	###	4	activation	activation	NN	NN	_	23	nsubj	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	5	of	of	IN	IN	_	9	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	6	the	the	DT	DT	_	9	det	_	_
transcription	NN	I-NP	B-protein	Other	Other	Other	Other	Other	###	7	transcription	transcription	NN	NN	_	9	compound	_	_
factor	NN	I-NP	I-protein	Other	Other	Other	Other	Other	###	8	factor	factor	NN	NN	_	9	compound	_	_
NF-kappaB	NN	I-NP	B-protein	Other	Other	Other	Other	Other	###	9	NF-kappaB	NF-kappaB	NN	NN	_	4	nmod	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	10	in	in	IN	IN	_	17	case	_	_
ex	FW	B-ADVP	O	Other	Other	Other	Other	Other	###	11	ex	ex	FW	FW	_	17	amod	_	_
vivo	FW	I-ADVP	O	Other	Other	Other	Other	Other	###	12	vivo	vivo	FW	FW	_	11	dep	_	_
isolated	VBN	B-NP	B-cell_type	Other	Other	Other	Other	Other	###	13	isolated	isolated	VBN	VBN	_	17	amod	_	_
peripheral	JJ	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	14	peripheral	peripheral	JJ	JJ	_	17	amod	_	_
blood	NN	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	15	blood	blood	NN	NN	_	17	compound	_	_
mononuclear	JJ	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	16	mononuclear	mononuclear	JJ	JJ	_	17	amod	_	_
cells	NNS	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	17	cells	cells	NNS	NNS	_	4	nmod	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	18	of	of	IN	IN	_	19	case	_	_
patients	NNS	B-NP	O	Other	Other	Other	Other	Other	###	19	patients	patients	NNS	NNS	_	17	nmod	_	_
with	IN	B-PP	O	Other	Other	Other	Other	Other	###	20	with	with	IN	IN	_	22	case	_	_
diabetes	NN	B-NP	O	Other	Other	Other	Other	Other	###	21	diabetes	diabetes	NN	NN	_	22	compound	_	_
mellitus	NN	I-NP	O	Other	Other	Other	Other	Other	###	22	mellitus	mellitus	NN	NN	_	19	nmod	_	_
correlates	VBZ	B-VP	O	Other	Other	Other	Other	Other	###	23	correlates	correlates	VBZ	VBZ	_	0	root	_	_
with	IN	B-PP	O	Other	Other	Other	Other	Other	###	24	with	with	IN	IN	_	26	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	25	the	the	DT	DT	_	26	det	_	_
degree	NN	I-NP	O	Other	Other	Other	Other	Other	###	26	degree	degree	NN	NN	_	23	nmod	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	27	of	of	IN	IN	_	29	case	_	_
diabetic	JJ	B-NP	O	Other	Other	Other	Other	Other	###	28	diabetic	diabetic	JJ	JJ	_	29	amod	_	_
nephropathy	NN	I-NP	O	Other	Other	Other	Other	Other	###	29	nephropathy	nephropathy	NN	NN	_	26	nmod	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	30	.	.	.	.	_	23	punct	_	_

NF-kappaB	NN	B-NP	B-protein	Other	Other	Other	Other	Other	###	1	NF-kappaB	NF-kappaB	NN	NN	_	2	compound	_	_
activation	NN	I-NP	O	Other	Other	Other	Other	Other	###	2	activation	activation	NN	NN	_	8	nsubj	_	_
is	VBZ	B-VP	O	Other	Other	Other	Other	Other	###	3	is	is	VBZ	VBZ	_	8	cop	_	_
at	IN	B-ADVP	O	Other	Other	Other	Other	Other	###	4	at	at	IN	IN	_	7	advmod	_	_
least	JJS	I-ADVP	O	Other	Other	Other	Other	Other	###	5	least	least	JJS	JJS	_	4	mwe	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	6	in	in	IN	IN	_	7	case	_	_
part	NN	B-NP	O	Other	Other	Other	Other	Other	###	7	part	part	NN	NN	_	8	nmod	_	_
dependent	JJ	B-ADJP	O	Other	Other	Other	Other	Other	###	8	dependent	dependent	JJ	JJ	_	0	root	_	_
on	IN	B-PP	O	Other	Other	Other	Other	Other	###	9	on	on	IN	IN	_	11	case	_	_
oxidative	JJ	B-NP	O	Other	Other	Other	Other	Other	###	10	oxidative	oxidative	JJ	JJ	_	11	amod	_	_
stress	NN	I-NP	O	Other	Other	Other	Other	Other	###	11	stress	stress	NN	NN	_	8	nmod	_	_
since	IN	B-PP	O	Other	Other	Other	Other	Other	###	12	since	since	IN	IN	_	19	mark	_	_
thioctic	JJ	B-NP	O	Other	Other	Other	Other	Other	###	13	thioctic	thioctic	JJ	JJ	_	14	amod	_	_
acid	NN	I-NP	O	Other	Other	Other	Other	Other	###	14	acid	acid	NN	NN	_	19	nsubj	_	_
(	(	O	O	Other	Other	Other	Other	Other	###	15	(	(	(	(	_	17	punct	_	_
alpha-lipoic	JJ	B-NP	O	Other	Other	Other	Other	Other	###	16	alpha-lipoic	alpha-lipoic	JJ	JJ	_	17	amod	_	_
acid	NN	I-NP	O	Other	Other	Other	Other	Other	###	17	acid	acid	NN	NN	_	14	appos	_	_
)	)	O	O	Other	Other	Other	Other	Other	###	18	)	)	)	)	_	17	punct	_	_
reduced	VBD	B-VP	O	Other	Other	Other	Other	Other	###	19	reduced	reduced	VBD	VBD	_	8	advcl	_	_
NF-kappaB	NN	B-NP	B-protein	Other	Other	Other	Other	Other	###	20	NF-kappaB	NF-kappaB	NN	NN	_	22	compound	_	_
binding	NN	I-NP	O	Other	Other	Other	Other	Other	###	21	binding	binding	NN	NN	_	22	compound	_	_
activity	NN	I-NP	O	Other	Other	Other	Other	Other	###	22	activity	activity	NN	NN	_	19	dobj	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	23	.	.	.	.	_	8	punct	_	_

